Track the 유한양행 stock price and the full insider trade history of the company, a listed issuer based in South Korea. Shares are listed on the KR market, under the authority of DART (FSS). Operating in the Health Care sector, 유한양행 has logged 111 insider filings. Market capitalisation: €6,197.9bn. The latest transaction was disclosed on 2 July 2026 (Purchase). Among the most active insiders: 김열홍. The full history is accessible without an account.
108
Insider Decl.
n/a
Thresholds
€195m
95 ops.
Buy Volume
n/a
7 ops.
Sell Volume
41Σ signal
Buys €195mn/a Sells
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental score
Ranked 16,376 of 29,062 companies
48.4
score / 100
Value
37
Quality
60
FCF yld-0.6%
Earn yld3.1%
EV/EBITDA21.3x
ROE9.5%
Gross mgn33%
Net mgn8.9%
Debt/EBITDA1.1x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
500 shares@ ₩93,974.000.0007% mcap100.0% of flowShareKRXDART:20260414002426
25 of 111 declarations
Acerca de 유한양행
Yuhan Corporation es una empresa farmacéutica surcoreana dedicada a la investigación, el desarrollo y la fabricación de medicamentos. Cotiza en la Bolsa de Corea, XKRX.